Invitro efficacy of niosome encapsulated fluoroquinolones against ciprofloxacin resistant bacterial strains and the invivo evaluation of niosome entrapped levofloxacin against ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus in an ineffective rat model